Skip to content

Definium Therapeutics, Inc.

DFTX· NasdaqCore metricsCIK 1813814

Medicinal chemicals & botanical products39 peers

Last sale
Nov 12, 2026 · -4.27%
Market cap
$4.52B
136.9M shares
Filings
508
—
—
—
-$50.96M
Q3 2026N/M FY25 yoy
-$72.28M
Q3 2026N/M FY25 yoy
—
—
—
-$0.46
Q3 2026N/M FY25 yoy
$241.15M
Q3 2026−5.8% FY25 yoy
$4.52B
—
—
4.7×
—
—

FY2025 figures · derived

Price

$32.99+146.38%+$19.60since Dec 31, 2025
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Net Interest Income

$4.66MFY 2023
$4.66M-$359.00K0FY 2020FY 2021FY 2022FY 2023
PeriodEndedValueKindSource trail
FY 20232023-12-31$4,664,000reported
FY 20222022-12-31$1,495,000reported
FY 20212021-12-31$359,000reported
FY 20202020-12-31$164,000reported

Medicinal chemicals & botanical products

Definium Therapeutics, Inc. is the largest of the 40 covered companies the SEC files under this code, by market cap. SIC 2833

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Definium Therapeutics, Inc. · CIK 1813814 · Engraved from SEC EDGAR